Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Overview
Learn About Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Luis Tarrats is an Otolaryngologist in Cayey, Puerto Rico. Dr. Tarrats and is rated as an Advanced provider by MediFind in the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). His top areas of expertise are Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Sinusitis, Empyema, Ethmoiditis, and Endoscopy.
Centro Medicina Pulmonar Dr Candelario Csp
Juan Candelario-Lanza is a Pulmonary Medicine provider in Caguas, Puerto Rico. Dr. Candelario-Lanza and is rated as an Experienced provider by MediFind in the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). His top areas of expertise are Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Empyema, Lung Nodules, and Idiopathic Pulmonary Fibrosis.
Sono X Ray Radiology Group
Roberto Gonzalez-Sala is a Radiologist in Caguas, Puerto Rico. Dr. Gonzalez-Sala and is rated as an Experienced provider by MediFind in the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). His top areas of expertise are Vertigo, Thyroid Nodule, Chronic Cough, and Brain Aneurysm.
Summary: ACT18421 is a multinational, randomized, double-blind, placebo-controlled, parallel-group, Phase 2 study with 3 treatment groups. The purpose of the study is to evaluate the efficacy, safety and tolerability of 2 dosing regimens of itepekimab compared to placebo in male and female participants with chronic rhinosinusitis without nasal polyps (CRSsNP) aged 18 years of age and older. Study details i...
Summary: The main objective of this study is to evaluate treatment outcomes of tezepelumab among participants with physician-determined surgery-eligible CRSwNP, with or without asthma. Study details include: 1. The study duration will be up to 40 weeks. 2. The treatment duration will be up to 24 weeks. 3. The visit frequency will be once every 4 weeks (Q4W).